Molecular engineering of antibodies for therapeutic and diagnostic purposes.
about
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future TherapiesThe development of immunoconjugates for targeted cancer therapyNovel camelid antibody fragments targeting recombinant nucleoprotein of Araucaria hantavirus: a prototype for an early diagnosis of Hantavirus Pulmonary SyndromeThermodynamics of antibody-antigen interaction revealed by mutation analysis of antibody variable regions.Generation of a rabbit single-chain fragment variable (scFv) antibody for specific detection of Bradyrhizobium sp. DOA9 in both free-living and bacteroid formsEngineering venom's toxin-neutralizing antibody fragments and its therapeutic potential.Fast track antibody V-gene rescue, recombinant expression in plants and characterization of a PfMSP4-specific antibody.Targeting membrane proteins for antibody discovery using phage display.Side effects of cytokines approved for therapy.Antibodies from plants for bionanomaterials.Camelid Single-Domain Antibodies As an Alternative to Overcome Challenges Related to the Prevention, Detection, and Control of Neglected Tropical Diseases.Role of the mobility of antigen binding site in high affinity antibody elucidated by surface plasmon resonance.Engineering a high-affinity humanized anti-CD24 antibody to target hepatocellular carcinoma by a novel CDR grafting design.Expression and characterization of a recombinant porcinized antibody against the E2 protein of classical swine fever virus.Production of Single-Chain Fv Antibodies Specific for GA-Pyridine, an Advanced Glycation End-Product (AGE), with Reduced Inter-Domain Motion.A Modular Receptor Platform To Expand the Sensing Repertoire of Bacteria.Preclinical Optimization of Antibody-based Radiopharmaceuticals for Cancer Imaging and Radionuclide Therapy - Model, Vector, and Radionuclide Selection.Development and characterization of an anti-rituximab monoclonal antibody panel.
P2860
Q26752558-2536EE58-BCB1-4E89-9050-6BCAC26800BCQ27021990-B379BBF5-501A-4BE2-A1D0-9D0635126581Q28543136-1F67B050-0A9F-4DD4-9427-D7CB0CCACEC6Q30374518-55D500B0-8A83-4766-B394-0E4AA61AC159Q33842345-56B51F10-3875-4EC9-875A-D8004A836F30Q34101828-0674A105-FA4D-41A5-8E07-6DD2895A3353Q35068156-2264F02D-47AA-4C39-B718-FD5D47A0178EQ36020577-98F32824-9BFA-4653-A183-04F3929A49AFQ38255698-B4AE74B9-9F60-4BC9-A268-C5DE99D9BD59Q38739385-92E5B398-920C-479D-B3DA-50DC58408A26Q39002539-52D7FC97-3148-49FB-A67E-B3843B33BCAAQ39505747-0688BF62-5DCB-4109-8879-B1E5A490C7D0Q41612710-0C594190-9BC9-474F-8AA3-28776DBD6E74Q45324116-DAEA2468-3E36-4662-A669-364B9FCC3D01Q47584726-3FC9FD4C-A1EE-4092-A862-4718E17ED179Q47634092-2EF25BF6-3734-4BCE-A52F-25F97C01F036Q48089417-C62907B1-EFC6-4804-B3B6-CD83670BA36CQ50140061-6435186C-A04E-4590-8DAB-C25DAA2911AF
P2860
Molecular engineering of antibodies for therapeutic and diagnostic purposes.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular engineering of antibodies for therapeutic and diagnostic purposes.
@en
type
label
Molecular engineering of antibodies for therapeutic and diagnostic purposes.
@en
prefLabel
Molecular engineering of antibodies for therapeutic and diagnostic purposes.
@en
P2860
P356
P1476
Molecular engineering of antibodies for therapeutic and diagnostic purposes.
@en
P2093
Bruno H Muller
Frédéric Ducancel
P2860
P304
P356
10.4161/MABS.20776
P577
2012-07-01T00:00:00Z